Biotage AB (publ) Stock Forecast for 2023 - 2025 - 2030
Updated on 04/19/2024
Biotage AB (publ) Stock Forecast and Price Target
If the average 2024 price target of kr200.00 recently set by two prominent experts for Biotage AB (publ) is met, there would be a potential upside of approximately 26.18% from the last closing price in April, 2024. The high estimate is kr200.00, and the low is kr160.00. You may be interested in rivals even if you aren't interested in Biotage AB (publ) stock.
26.18% Upside
Biotage AB (publ) Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Biotage AB (publ)'s Price has decreased from kr133.61 to kr0.00 – a 100.00% drop. In the next year, analysts predict that Fair Value will reach kr131.13 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| INSP Stock Forecast | Insplorion AB (publ) | - |
0
|
kr2.10 | Buy/Sell | kr25.00 | -100.00% |
| MIR Stock Forecast | Miris Holding AB (publ) | - |
0
|
kr0.75 | Buy/Sell | kr0.00 | -100.00% |
| PHI Stock Forecast | Phase Holographic Imaging PHI ... | - |
4
|
kr5.30 | Buy/Sell | kr0.00 | -100.00% |
| PEXA B Stock Forecast | PExA AB (publ) | - |
5
|
kr0.44 | Buy/Sell | kr0.00 | -100.00% |
| PHLOG B Stock Forecast | Pharmacolog i Uppsala AB (publ... | - |
8
|
kr0.08 | Buy/Sell | kr0.00 | -100.00% |
Biotage AB (publ) Revenue Forecast for 2023 - 2025 - 2030
Biotage AB (publ)'s Revenue has grown in the last two years, jumping from kr1.09B to kr1.57B – an increase of 43.37%. In the following year, 0 experts forecast that Biotage AB (publ)'s Revenue will decrease by 18.00%, to kr1.28B. In 2030, professionals predict that Biotage AB (publ)'s Revenue will decrease by 16.29%, to kr1.31B.
.jpg)
Biotage AB (publ) Dividend per Share Forecast for 2023 - 2025 - 2030
In the last two years, Biotage AB (publ)'s Dividend per Share has increased by 6.67%, going from kr1.50 to kr1.60. 3 analysts predict Biotage AB (publ)'s Dividend per Share will decrease by 1.25% in the next year, reaching kr1.58. The Biotage AB (publ) forecast is for Dividend per Share to reach kr1.69 or grow by 5.93%.
Biotage AB (publ) EBITDA Forecast for 2023 - 2025 - 2030
Biotage AB (publ)'s EBITDA has increased by 65.25% In the last two years, going from kr217.25M to kr359.00M. In the next year, analysts expect EBITDA to reach kr499.67M – an increase of 39.18%. For the next seven years, the forecast is for EBITDA to grow by 89.37%.
Biotage AB (publ) EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Biotage AB (publ)'s EBIT has grown, increasing from kr188.20M to kr308.00M – a growth of 63.66%. The next year looks promising for Biotage AB (publ), with analysts predicting EBIT of kr327.33M – an increase of 6.28%. Over the next seven years, experts anticipate that Biotage AB (publ)'s EBIT will grow at a rate of 98.61%.
Biotage AB (publ) EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Biotage AB (publ)'s EPS has decreased from kr2.69 to kr0.00 – a 100.00% drop. In the next year, analysts predict that EPS will reach kr2.64 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.
.jpg)